| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA136624
Max Phase: Preclinical
Molecular Formula: C21H26N2O4
Molecular Weight: 370.45
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: CCCCC(C(=O)Nc1ccc(O)cc1C)C(=O)Nc1ccc(O)cc1C
Standard InChI: InChI=1S/C21H26N2O4/c1-4-5-6-17(20(26)22-18-9-7-15(24)11-13(18)2)21(27)23-19-10-8-16(25)12-14(19)3/h7-12,17,24-25H,4-6H2,1-3H3,(H,22,26)(H,23,27)
Standard InChI Key: VZBDFVVRAGCYEC-UHFFFAOYSA-N
Associated Targets(Human)
Cyclooxygenase 1258 Activities
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 370.45 | Molecular Weight (Monoisotopic): 370.1893 | AlogP: 4.10 | #Rotatable Bonds: 7 |
| Polar Surface Area: 98.66 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 4 |
| #RO5 Violations: 0 | HBA (Lipinski): 6 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: 9.27 | CX Basic pKa: | CX LogP: 4.83 | CX LogD: 4.83 |
| Aromatic Rings: 2 | Heavy Atoms: 27 | QED Weighted: 0.44 | Np Likeness Score: -0.23 |
References
| 1. Vennerstrom JL, Holmes TJ.. (1987) Prostaglandin-H synthase inhibition by malonamides. Ring-opened analogues of phenylbutazone., 30 (2): [PMID:3100804] [10.1021/jm00385a031] |
Source
Source(1):